Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Chapter 10: transcriptional regulation Fig. 10-1 Regulation of Gene Transcription DNA-binding proteins • RNA polymerase binding to the transcription initiation site (e.g., promoter) • Regulatory protein(s) binding to other sites (e.g., operator) • Regulatory protein binding can positively or negatively regulate transcription Positive/negative regulation: binding of activator or repressor proteins Fig. 10-2 Regulation of Gene Transcription DNA-binding proteins • RNA polymerase binding to the transcription initiation site (e.g., promoter) • Regulatory protein(s) binding to other sites (e.g., operator) • Regulatory protein binding can positively or negatively regulate transcription • Protein affinity for DNA or for other proteins can be influenced by allosteric conformation Effector binding mediates allosteric change Effector promotes activator binding Effector prevents repressor binding Fig. 10-3 Fig. 10-5 In mammalian newborns, lactose is the principal sugar source for intestinal flora Lactose utilization by E. coli • -linked disaccharide peculiar to milk • lac genes encode a glycosidase and proteins that promote cellular import of lactose • Genes are transcribed only in the presence of lactose (inducible) and the absence of glucose (catabolite repression) • Genes are organized into a co-transcribed cluster (operon; encodes a polycistronic mRNA) lac operon in E. coli (simplified schematic) Fig. 10-4 lac operon in E. coli (dynamic schematic) Fig. 10-6 Fig. 10-8 Fig. 10-9 Fig. 10-10 Effects of mutations within consensus sequences of E. coli promoters Fig. 10-11 Effects of lac operator mutations Fig. 10-12 E. coli lac is also regulated by catabolite repression • Regulates preferential utilization of glucose • Mediated by cAMP (glucose-responsive) • cAMP is effector of catabolite activator protein (CAP) • cAMP-CAP binds to lac promoter, enhancing binding of RNA polymerase Fig. 10-13 Fig. 10-13 Activated CAP binding induces a distortion of its DNA binding site “presents” P region to RNA polymerase Fig. 10-15 Molecular organization of the lac promoter region Fig. 10-16 Cumulative regulatory control of lac transcription Fig. 10-17 Cumulative regulatory control of lac transcription Fig. 10-17 “Negative control” (repression) “Positive control” (activation) Fig. 10-18 Typical 5’ end sequences found in eukaryote genes (promoter and nearby elements) RNA polymerase binding site Fig. 10-22 β-globin promoter region and effects of mutation Fig. 10-23 Consensus sequences predict important regions which experiments can often confirm Eukaryote polymerase binding and transcription initiation are determined by cooperative interactions of diverse proteins with diverse DNA sequences Enhancer-binding factors can be tissue-specific Near DNA sequences: promoter-proximal elements Fig. 10-24 Distance-independent DNA sequences: enhancers/silencers Drosophila dpp gene region contains many tissue-specific enhancers Visceral mesoderm enhancer (VM) Lateral mesoderm enhancer (LE) Fig. 10-27 Imaginal disk enhancer (ID) Most tissue/cell-specific gene expression in eukaryotes is controlled by enhancers Chromosome rearrangements that create new physical relationships among genes can result in gain-of-function mutation The In(3R)Tab mutation brings into close proximity: • sr enhancer sequences (drive thorax expression) • Abd-B gene (product drives expression of abdominal pigmentation) +/+ Fig. 10-28 Tab/+ Chromatin structure influences gene expression Euchromatin: rich in active genes Heterochromatin: Constitutive heterochromatin (e.g., centromere regions) few active genes Facultative heterochromatin: euchromatin in some cells, heterochromatic in others rich in genes; genes are transcriptionally silent Epigenetic inheritance: inheritance of genes with same DNA sequence, but different levels of expression Mammalian X-chromosome heterochromatization • dosage compensation • inactivation of one X in female cells (heterochromatic X is “Barr body”) • selection of X occurs in early embryo (then is fixed for clonal populations) • mammalian females mosaically express their X-linked genes Fig. 10-30 Imprinting: recently discovered in mammals DNA methylation usually results in reduced levels of gene expression Differential methylation of genes and transmission of that methylation can result in imprinting phenomena Fig. 10-32 Prader-Willi syndrome can arise “de novo” through a combination of mutation and imprinting Fig. 10-31 Position-effect variegation (PEV): relocation of euchromatic genes to the vicinity of heterochromatin can result in mosaic inactivation Fig. 10-34 Clonal-determined heterochromatin spreading Fig. 10- Fig. 10-